JAIME TURNER: Open Payments
NPI 1174902795 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 21 payments from 8 companies in 2025. Trend: 2023 $363 · 2024 $456 · 2025 $595
Food & beverage: $505Education: $90
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $229 |
| GENZYME CORPORATION | 4 | $91 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Regeneron Healthcare Solutions, Inc. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Ionis Pharmaceuticals, Inc. | 1 | $33 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, DAWNZERA, VOQUEZNA, INSPIRE.
Industry payments across AR — which companies pay providers there.
